Spots Global Cancer Trial Database for cervix cancer
Every month we try and update this database with for cervix cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Multimodal Monitoring of Radiotherapy Response in Squamous Cell Cancer | NCT02379039 | Squamous Carcin... Head and Neck C... Anal Cancer Lung Cancer Esophageal Canc... Cervix Cancer | 18 Years - | Umeå University | ||
| Validation of the Genetic Signature 354849 as a Prognostic Method | NCT04067882 | Cervix Cancer | Genetic signatu... | 18 Years - | National Institute of Cancerología | |
| The Effectiveness of the Screening Inventory of Psychosocial Problems (SIPP) in Cancer Patients | NCT00859768 | Breast Cancer Lung Cancer Prostate Cancer Bladder Cancer Cervix Cancer Cancer of Endom... Cancer of Skin Non-Hodgkin Lym... Colorectal Canc... | Questionnaire a... | 18 Years - | Netherlands Open University | |
| Study of a Predictor for Cervix Cancer | NCT01641484 | Cervix Cancer Oncology | local control a... | 18 Years - 65 Years | Centre Oscar Lambret | |
| Prolonged Grief and Perception of Femininity in Gynecological Cancer Patients | NCT05529303 | Cervix Cancer Uterine Cancer Ovarian Cancer Endometrial Can... Vulva Cancer Grief Femininity | Such as art the... | 18 Years - 65 Years | Afyonkarahisar Health Sciences University | |
| 2D vs 3D Planning for High-Dose Rate (HDR) Gynecological Brachytherapy | NCT02091050 | Cervix Cancer Endometrial Can... | 2D HDR planning 3D HDR planning | 18 Years - 85 Years | AC Camargo Cancer Center | |
| PRGN-2009 in Combination With Pembrolizumab Versus Pembrolizumab in Patients With Recurrent or Metastatic Cervical Cancer | NCT06157151 | Cervical Cancer HPV-Related Car... HPV-Related Mal... | PRGN-2009 plus ... Pembrolizumab a... | 18 Years - | Precigen, Inc | |
| Clinical Evaluation of the APTIMA® HPV 16 18/45 Genotype Assay on the PANTHER® System | NCT01694875 | Human Papilloma... | APTIMA HPV Assa... | 21 Years - | Gen-Probe, Incorporated | |
| Honduras Liger Thermocoagulator Study | NCT03510273 | Cervix Cancer Cervix Lesion | Liger Medical T... | 30 Years - 49 Years | PATH | |
| Development of Clinically High Efficient Platforms for Individualised Treatment of Cervix Cancer | NCT05102240 | Cervix Cancer | 18 Years - 90 Years | Tata Memorial Hospital | ||
| HPV Self-sampling for Women Who do Not Attend Cervical Cancer Screening Programme | NCT06371118 | Papillomavirus ... Early Detection... Cervix Cancer Self-Examinatio... | Directly mailed... Mailed self-sam... Standard of car... | 26 Years - 60 Years | Universidade do Porto | |
| A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas. | NCT06022029 | Triple Negative... Diffuse Large B... Follicular Lymp... Lymphoma, Non-H... Mantle Cell Lym... Bladder Cancer Uveal Melanoma,... Cervix Cancer Carcinoma in Si... Head and Neck S... Skin Cancer Metastatic Canc... Tumor, Solid Tumor Recurrenc... | ONM-501 Cemiplimab | 18 Years - | OncoNano Medicine, Inc. | |
| PRGN-2009 in Combination With Pembrolizumab Versus Pembrolizumab in Patients With Recurrent or Metastatic Cervical Cancer | NCT06157151 | Cervical Cancer HPV-Related Car... HPV-Related Mal... | PRGN-2009 plus ... Pembrolizumab a... | 18 Years - | Precigen, Inc | |
| Survival Monitoring in Russian Cancer Registries | NCT06043947 | Melanoma Breast Cancer Oncology Colon Cancer Prostate Cancer Survivorship Lung Cancer Cervix Cancer | 0 Years - 100 Years | N.N. Petrov National Medical Research Center of Oncology | ||
| Glutaminase Inhibition and Chemoradiation in Advanced Cervical Cancer | NCT05521997 | Advanced Cervic... Cervical Cancer Cervix Cancer Cancer of the C... | Telaglenastat Radiation treat... Cisplatin | 18 Years - | Washington University School of Medicine | |
| Study of Zoledronic Acid Versus Observation on Bone Mineral Density and Incidence of Micrometastasis in Women Undergoing Pelvic Radiation for Cervical Cancer | NCT00966992 | Uterine Cervica... | Zoledronic acid | 18 Years - | Washington University School of Medicine | |
| Dosimetric Analysis of Vaginal Cuff Brachytherapy in Endometrial Carcinoma | NCT00165126 | Endometrial Car... Cervix Cancer Carcinoma of th... | Radiation thera... | 18 Years - 90 Years | Dana-Farber Cancer Institute | |
| Effectiveness of Care in Certified Cancer Centres in Germany | NCT04334239 | Colorectal Canc... Breast Cancer Ovarian Cancer Cervix Cancer Endometrial Can... Bronchial Cance... Prostate Cancer Head and Neck T... CNS Tumor Pancreatic Canc... | Oncological cer... | 18 Years - | Technische Universität Dresden | |
| The Effect of Logotherapy on Mental Health in Gynecological Cancer Patients | NCT05246462 | Cancer of Ovary Endometrium Can... Cervix Cancer | Logotherapy | 18 Years - | Akdeniz University | |
| Minimally Invasive Simple Hysterectomy in Low Risk Cervical Cancer | NCT06416748 | Cervical Cancer Cervix Cancer | Minimally invas... | 18 Years - | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | |
| Concomitant Chemoradiation in Advanced Stage Carcinoma Cervix | NCT00193791 | Cancer of Cervi... | CT + RT | 18 Years - 65 Years | Tata Memorial Hospital | |
| Tisotumab Vedotin (HuMax®-TF-ADC) Safety Study in Patients With Solid Tumors | NCT02552121 | Ovary Cancer Cervix Cancer Endometrium Can... Bladder Cancer Prostate Cancer... Esophagus Cance... Lung Cancer (NS... | Tisotumab vedot... | 18 Years - | Seagen Inc. | |
| Opioid Free Anaesthesia in Oncologic Gynaecological Surgery: Is There Any Benefit? | NCT05448586 | Cervix Cancer Endometrial Can... Ovarian Cancer Breast Cancer | Opioid | 20 Years - 91 Years | Instituto de Investigación Hospital Universitario La Paz | |
| A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas. | NCT06022029 | Triple Negative... Diffuse Large B... Follicular Lymp... Lymphoma, Non-H... Mantle Cell Lym... Bladder Cancer Uveal Melanoma,... Cervix Cancer Carcinoma in Si... Head and Neck S... Skin Cancer Metastatic Canc... Tumor, Solid Tumor Recurrenc... | ONM-501 Cemiplimab | 18 Years - | OncoNano Medicine, Inc. | |
| Prospective Evaluation of Patients With Uterine Cervical Cancer in Brazilian Health Institutions - The EVITA I Study | NCT02671071 | Cervix Cancer | Quality of Life... | 18 Years - | Latin American Cooperative Oncology Group | |
| Dosimetric Planning Study Comparing Intensity Modulated Radiotherapy (IMRT) and 4-field Radiotherapy for Definitive Treatment of Cancer of the Cervix | NCT00981552 | Cervix Cancer | IMRT planning 4-Field Radiati... | - | Sunnybrook Health Sciences Centre | |
| Chemotherapy and Pelvic Hypofractionated Radiation Followed by Surgery Cervical Cancer | NCT03750539 | Cervix Cancer | Standard radiot... hypofractionate... Radical hystere... | 18 Years - 80 Years | National Institute of Cancerología | |
| Development and Validation of a Risk Prediction Model for Venous Thromboembolism in Gynecological Cancer Patients Undergoing Systemic Antineoplastic Treatment: The Gynecological Cancer Associated Thrombosis (GynCAT) Study | NCT06284343 | Cancer-associat... Venous Thromboe... Gynecologic Can... Ovarian Cancer Cervix Cancer Endometrial Can... Vaginal Cancer | Anticoagulant | 18 Years - | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | |
| Pharmacokinetics of Intravaginal, Self-administered Artesunate Vaginal Pessaries Among Women in Kenya | NCT06263582 | Cervix Cancer Cervix Intraepi... Cervix; Intraep... Cervix; Intraep... | Artesunate pess... blood draws for... | 18 Years - 65 Years | UNC Lineberger Comprehensive Cancer Center | |
| Study of Tumour Response to Tirapazamine During Treatment of Cervical Cancer | NCT00493376 | Cervix Cancer | Cervical tissue... Biopsy: Measure... Biopsy: Immunoh... Measurement of ... | 18 Years - | British Columbia Cancer Agency | |
| Development of Clinically High Efficient Platforms for Individualised Treatment of Cervix Cancer | NCT05102240 | Cervix Cancer | 18 Years - 90 Years | Tata Memorial Hospital | ||
| Optimized Magnetic Resonance Brachytherapy (MR BT) in Cervix Cancer | NCT00938106 | Cervix Cancer | optimised magne... | 18 Years - | University Health Network, Toronto | |
| 2D vs 3D Planning for High-Dose Rate (HDR) Gynecological Brachytherapy | NCT02091050 | Cervix Cancer Endometrial Can... | 2D HDR planning 3D HDR planning | 18 Years - 85 Years | AC Camargo Cancer Center | |
| Evaluating Scaleup of an Adapted Breast Cancer Early Diagnosis Program in Rwanda | NCT05364138 | Breast Cancer Benign Breast D... Cervix Cancer | - | Brigham and Women's Hospital | ||
| Dosimetric Analysis of Vaginal Cuff Brachytherapy in Endometrial Carcinoma | NCT00165126 | Endometrial Car... Cervix Cancer Carcinoma of th... | Radiation thera... | 18 Years - 90 Years | Dana-Farber Cancer Institute | |
| A Clinical Study of Anti-CD70 UCAR-T in Relapsed or Refractory Solid Tumors | NCT06383507 | Metastatic Tumo... Advanced Solid ... Renal Cell Carc... Ovarian Cancer Cervix Cancer Head and Neck S... Nasopharyngeal ... | CHT101 | 18 Years - 75 Years | Zhejiang University | |
| Study of Pembrolizumab and Lenvatinib in Metastatic and Recurrent Cervix Cancer (LenPem Cervix) | NCT06266338 | Cervix Cancer Cervical Cancer | Pembrolizumab Lenvatinib | 18 Years - | University of Texas Southwestern Medical Center | |
| Prognostic and Diagnostic Added Value of Medical Imaging in Gynecological Cancer (PRODIGYN) | NCT05855941 | Cervix Cancer Endometrial Can... Epithelial Ovar... | FDG-PET/CT and ... | 18 Years - | Region Västerbotten | |
| Study of Pembrolizumab and Lenvatinib in Metastatic and Recurrent Cervix Cancer (LenPem Cervix) | NCT06266338 | Cervix Cancer Cervical Cancer | Pembrolizumab Lenvatinib | 18 Years - | University of Texas Southwestern Medical Center | |
| Postoperative Hypofractionated Intensity-modulated Radiation Therapy in Cervical Cancer | NCT03239626 | Cervix Cancer Radiotherapy, A... Radiotherapy, I... Hypofractionate... | POHIM-RT | 20 Years - 70 Years | Samsung Medical Center | |
| Prognostic Value of Conization and Negative HPV After Conization in AIS and Early Stage Cervical Cancer | NCT06196190 | Cervix Cancer HPV-Related Mal... | 18 Years - 85 Years | Rambam Health Care Campus | ||
| Investigation of Cervix Tumor Oxygenation and Microvasculature Using Magnetic Resonance Techniques | NCT00242034 | Cervix Cancer | CT and MRI with... | 18 Years - | University Health Network, Toronto | |
| Cervical Cancer Screening Based on First-void Urine Self-sampling to Reach un(Der)-Screened Women: ScreenUrSelf Trial | NCT05996783 | Cervix Cancer Cervical Intrae... Human Papilloma... HPV-Related Cer... | Colli-Pee Small... Evalyn Brush | 31 Years - 64 Years | Universiteit Antwerpen | |
| High Dose Rate (HDR) Versus Low Dose Rate (LDR) Brachytherapy in Carcinoma Cervix | NCT00193830 | Cancer of Cervi... Cervical Cancer Cancer of the C... Cervix Cancer | HIgh Dose Rate ... | 18 Years - 65 Years | Tata Memorial Hospital | |
| Phase II Study , Association of Cisplatine Topotecan and Cetuximab in Patients Whith Late or in Progress Epithelial Cancer of the Cervix | NCT00518193 | Cervix Cancer | ERBITUX | 18 Years - | ARCAGY/ GINECO GROUP | |
| Fluorescence for Sentinel Lymph Node Identification in Cancer Surgery | NCT02997553 | Breast Carcinom... Head and Neck C... Melanoma (Skin) Squamous Cell C... Cervix Cancer Endometrium Can... Ovary Cancer Vulva Cancer Anus Cancer Rectum Cancer | Indocyanine gre... Technetium99 Optonuclear pro... Quest Camera | 18 Years - | Institut de Cancérologie de Lorraine | |
| Chemotherapy and Pelvic Hypofractionated Radiation Followed by Surgery Cervical Cancer | NCT03750539 | Cervix Cancer | Standard radiot... hypofractionate... Radical hystere... | 18 Years - 80 Years | National Institute of Cancerología | |
| A Study of SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors | NCT05864144 | Solid Tumor, Ad... Advanced Solid ... Head and Neck C... Breast Cancer Colon Cancer Pancreatic Canc... Gastric Cancer Esophageal Canc... Prostate Cancer Uterine Cancer Cervix Cancer Ovarian Cancer Kidney Cancer Bladder Cancer Thyroid Cancer Melanoma Sarcoma Advanced Cancer Metastatic Canc... Refractory Canc... Non Small Cell ... | SNS-101 (anti-V... Cemiplimab | 18 Years - | Sensei Biotherapeutics, Inc. | |
| Anti-PD-1 Antibody Combined With Histone Deacetylase Inhibitor in Patients With Advanced Cervical Cancer | NCT04651127 | Cervical Cancer Cervix Cancer Cervix Neoplasm | Toripalimab + C... | 18 Years - 70 Years | Sun Yat-sen University | |
| A Trial Comparing Intensity Modulated Radiation Therapy (IMRT) With Conventional Radiation Therapy in Stage IIB Carcinoma Cervix | NCT00193804 | Cancer of Cervi... | IMRT | 18 Years - 65 Years | Tata Memorial Hospital | |
| Online Adaptive Radiotherapy Using a Novel Linear Accelerator (ETHOS) | NCT06116019 | Prostate Cancer Head and Neck C... NSCLC SCLC Esophageal Canc... Bladder Cancer Rectum Cancer Cervix Cancer Other Carcinoma | Online adaptive... | 18 Years - | Charite University, Berlin, Germany | |
| Effectiveness of Care in Certified Cancer Centres in Germany | NCT04334239 | Colorectal Canc... Breast Cancer Ovarian Cancer Cervix Cancer Endometrial Can... Bronchial Cance... Prostate Cancer Head and Neck T... CNS Tumor Pancreatic Canc... | Oncological cer... | 18 Years - | Technische Universität Dresden | |
| Tisotumab Vedotin (HuMax®-TF-ADC) Safety Study in Patients With Solid Tumors | NCT02001623 | Ovary Cancer Cervix Cancer Endometrium Can... Bladder Cancer Prostate Cancer... Esophagus Cance... Lung Cancer(NSC... Squamous Cell C... | Tisotumab Vedot... | 18 Years - | Seagen Inc. | |
| Cancer Prevention and Treatment Among African American Older Adults: Treatment Trial | NCT00509444 | Breast Cancer Colon Cancer Rectum Cancer Cervix Cancer Prostate Cancer Lung Cancer | Educational mat... educational mat... | 65 Years - | Johns Hopkins Bloomberg School of Public Health | |
| Tisotumab Vedotin (HuMax®-TF-ADC) Safety Study in Patients With Solid Tumors | NCT02001623 | Ovary Cancer Cervix Cancer Endometrium Can... Bladder Cancer Prostate Cancer... Esophagus Cance... Lung Cancer(NSC... Squamous Cell C... | Tisotumab Vedot... | 18 Years - | Seagen Inc. | |
| Neoadjuvant Chemotherapy Followed by Surgery Versus Concurrent Chemoradiation in Carcinoma of the Cervix | NCT00193739 | Cancer of Cervi... | NACT Radical abdomin... Inj.Cisplatin Concurrent chem... | 18 Years - 65 Years | Tata Memorial Hospital | |
| Evaluating Scaleup of an Adapted Breast Cancer Early Diagnosis Program in Rwanda | NCT05364138 | Breast Cancer Benign Breast D... Cervix Cancer | - | Brigham and Women's Hospital | ||
| COL Immunotherapy Before Radiochimio + Ipilimumab | NCT04256213 | Cervix Cancer | Nivolumab and I... | 18 Years - | ARCAGY/ GINECO GROUP | |
| Carboplatin-cyclophosphamide Combined With Atezolizumab | NCT02914470 | Breast Cancer Cervix Cancer Ovarian Cancer Endometrial Can... | carbplatin, cyc... | 18 Years - | The Netherlands Cancer Institute | |
| Niraparib in Combination With Dostarlimab in Patients With Recurrent or Progressive Cervix Cancer | NCT04068753 | Recurrent Cervi... Progressive Cer... | Niraparib dostarlimab | 18 Years - | University of Oklahoma | |
| Sexual Functioning in Cervical Cancer Survivors | NCT00522223 | Cervical Cancer | Questionnaire | - | M.D. Anderson Cancer Center | |
| Study of Zoledronic Acid Versus Observation on Bone Mineral Density and Incidence of Micrometastasis in Women Undergoing Pelvic Radiation for Cervical Cancer | NCT00966992 | Uterine Cervica... | Zoledronic acid | 18 Years - | Washington University School of Medicine | |
| Combination of PD-1 Monoclonal Antibody and HPV Vaccine in Patients With Cervical Cancer | NCT04096911 | Uterine Cervica... Cervical Cancer Cervical Neopla... Cervix Cancer | Sintilimab quadrivalent HP... | 18 Years - | Northern Jiangsu People's Hospital | |
| Prevention and Screening Towards Elimination of Cervical Cancer | NCT05234112 | HPV Infection Cervix Cancer Cervical Dyspla... | Community mobil... hrHPV self-test... Follow-up after... VIA Thermo-ablation... Pap smear cytol... | 30 Years - 60 Years | University Medical Center Groningen | |
| Adjuvant Chemotherapy in cfHPV-DNA Plasma Positive Patients: A Biomarker In Locally Advanced Cervical Cancer | NCT05764044 | Cervical Cancer Cervix Cancer Cervix Neoplasm | cisplatin, gemc... Follow-up | 18 Years - 70 Years | Hospital do Coracao | |
| Tisotumab Vedotin Continued Treatment in Patients With Solid Tumors. | NCT03245736 | Ovary Cancer Cervix Cancer Endometrium Can... Bladder Cancer Prostate Cancer Esophagus Cance... Lung Cancer, No... Squamous Cell C... | Tisotumab Vedot... | 18 Years - | Seagen Inc. | |
| A Trial Using Velcade Plus Chemoradiation for Central Nervous System, Head and Neck, and Cervical Cancer Patients | NCT00329589 | Brain Cancer Head and Neck C... Cervix Cancer Central Nervous... | Velcade (bortez... | 18 Years - | Thomas Jefferson University | |
| Metronomic Oral Vinorelbine Plus Anti-PD-L1/Anti-CTLA4 ImmunothErapy in Patients With Advanced Solid Tumours | NCT03518606 | Advanced Solid ... Breast Cancer Head and Neck C... Cervix Cancer Prostate Cancer | Durvalumab + Tr... | 18 Years - | UNICANCER | |
| Women's Knowledges About Gynaecological Aftercare | NCT03589352 | Gynecology | 18 Years - | University Hospital, Strasbourg, France | ||
| A Clinical Research About CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Solid Tumors | NCT06010875 | Renal Cell Carc... Ovarian Cancer Cervix Cancer Metastatic Canc... Advanced Cancer | CD70 CAR-T cell... CD70 CAR-T cell... | 18 Years - | Chongqing Precision Biotech Co., Ltd | |
| Cervix Hypoxia FAZA | NCT01549730 | Cervix Cancer | 18F-Fluoroazomy... | 18 Years - | University Health Network, Toronto | |
| A Study of Pembrolizumab And Platinum With Radiotherapy in Cervix Cancer | NCT03144466 | Cervix Cancer | Pembrolizumab | 18 Years - | Royal Marsden NHS Foundation Trust | |
| Cancer Prevention and Treatment Among African American Older Adults: Treatment Trial | NCT00509444 | Breast Cancer Colon Cancer Rectum Cancer Cervix Cancer Prostate Cancer Lung Cancer | Educational mat... educational mat... | 65 Years - | Johns Hopkins Bloomberg School of Public Health | |
| Matrix Metalloproteinases and Human Papillomavirus in Dysplasias and Cancers of the Cervix | NCT04072913 | Papillomavirus ... Dysplasia Cervix Cancer | Vaginal samples... | 20 Years - 65 Years | University Hospital, Bordeaux | |
| Multimodal Monitoring of Radiotherapy Response in Squamous Cell Cancer | NCT02379039 | Squamous Carcin... Head and Neck C... Anal Cancer Lung Cancer Esophageal Canc... Cervix Cancer | 18 Years - | Umeå University | ||
| A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas. | NCT06022029 | Triple Negative... Diffuse Large B... Follicular Lymp... Lymphoma, Non-H... Mantle Cell Lym... Bladder Cancer Uveal Melanoma,... Cervix Cancer Carcinoma in Si... Head and Neck S... Skin Cancer Metastatic Canc... Tumor, Solid Tumor Recurrenc... | ONM-501 Cemiplimab | 18 Years - | OncoNano Medicine, Inc. | |
| A Clinical Research About CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Gynecologic Cancer | NCT06215950 | Ovarian Cancer Cervix Cancer Metastatic Canc... Advanced Cancer Gynecologic Can... | CD70 CAR-T cell... CD70 CAR-T cell... | 18 Years - | Chongqing Precision Biotech Co., Ltd | |
| Sexual Functioning in Cervical Cancer Survivors | NCT00522223 | Cervical Cancer | Questionnaire | - | M.D. Anderson Cancer Center | |
| Evaluating Scaleup of an Adapted Breast Cancer Early Diagnosis Program in Rwanda | NCT05364138 | Breast Cancer Benign Breast D... Cervix Cancer | - | Brigham and Women's Hospital | ||
| Impact of a Sexological Follow-up on the Sexual Function in Patients With Cervix or Vaginal Cancer Treated by Radiotherapy and Brachytherapy | NCT03956498 | Cervix Cancer Vaginal Cancer | Patients with c... | 18 Years - | Institut Claudius Regaud |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
